| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應商 |
| 75513-72-3 | N,N'-二庚基-N,N'-二甲基-1,4-丁烷二酰胺; N,N'-二庚基-N,N'-二甲基-1,4-丁烷二酰胺 | ETH 1117; ETH 1117; MAGNESIUM IONOPHORE I; MAGNESIUM IONOPHORE I - COCKTAIL A; MAGNESIUM-LIGAND; N,N'-DIHEPTYL-N,N'-DIMETHYL-1,4-BUTANEDIAMIDE; TIMTEC-BB SBB009103; ETH 1117, Magnesium-ligand, N,Nμ-Diheptyl-N,Nμ-dimethyl-1,4-butanediamide; N,N'-Diheptyl-N,N'-dimethylbutanediamide |  | C20H40N2O2 | 詳情 | 供應商 |
| 411208-45-2 | MADAM DIHYDROCHLORIDE |  | C16H20N2S.2ClH | 詳情 | 供應商 | |
| 347841-48-9 | 氘代馬拉硫磷; 氘代馬拉硫磷 | MALATHION (D10); MALATHION (D10); MALATHION-D10 (DIETHYL-D10) |  | C10H9D10O6PS2 | 詳情 | 供應商 |
| 948595-09-3 | O-[N-(6-Maleimidohexanoyl)aminoethyl]-Oμ-[3-(N-succinimidyloxy)-3-oxopropyl]polyethylene glycol 3 | 無 | 詳情 | 供應商 | ||
| 99524-14-8 | MALONIC ACID (1,3-13C2); MALONIC ACID (1,3-13C2); MALONIC-1,3-13C2 ACID; MALONIC-1,3-13C2 ACID, 99 ATOM % 13C |  | C(13C)2H4O4 | 詳情 | 供應商 | |
| 215312-86-0 | 無 | 詳情 | 供應商 | |||
| 34696-66-7 | 無 | 詳情 | 供應商 | |||
| 359436-59-2 | 4-(Maleimidomethyl)cyclohexane-1-carboxyl-hydrazide, Trifluoroacetic Acid |  | C14H18F3N3O5 | 詳情 | 供應商 | |
| 887406-71-5 | 無 | 詳情 | 供應商 | |||
| 211236-68-9 | Sulfo-Kmus |  | C19H25N2O9S.Na | 詳情 | 供應商 | |
| 84632-71-3 | MANNOTRIOSE-DI-(N-ACETYLGLUCOSAMINE), BIS(GALACTOSYL-N-ACETYLGLUCOSAMINYL)-BISECTING N-ACETYLGLUCOSA; MANNOTRIOSE-DI-(N-ACETYLGLUCOSAMINE), BIS(GALACTOSYL-N-ACETYLGLUCOSAMINYL)-BISECTING N-ACETYLGLUCOSAMINYL-; [GAL-GLCNAC]2[GLCNAC]MAN3GLCNAC2; NA2B; MANNOTRIOSE-DI-(N-ACETYLGLUCOSAMINE), BI S(GALACTOSYL-N-ACETYLGLUCOSAMINYL)-BIS; na2b glycan; Asialo, galactosylated, biantennary N-glycan, bisecting GlcNAc, (Gal-GlcNAc)2(GlcNAc)Man3(GlcNAc)2, Mannotriose-di-(N-acetylglucosamine), bis(galactosyl-N-acetylglucosaminyl)-bisecting N-acetylglucosaminyl-; Asialo, galactosylated, biantennary glycan, bisecting GlcNAc (NA2B) | 無 | C70H117N5O51 | 詳情 | 供應商 | |
| 9049-98-3 | 無 | 詳情 | 供應商 | |||
| 571188-30-2 | MANNOTRIOSE-(FUCOSYL-DI-(N-ACETYL-*GUCOS AMINE)), MO; MANNOTRIOSE-(FUCOSYL-DI-(N-ACETYL-*GUCOS AMINE)), MO; a1f glycan ammonium salt from human fibrinogen; mannotriose-(fucosyl-di-[n-acetylglucosamine]),mono-sialyl-bis(galactosyl-n-acetylglucosaminyl); A1F Glycan ammonium salt; NeuNAc(Gal-GlcNAc)2Man3(GlcNAc)2Fuc, Mannotriose-(fucosyl-di-[N-acetylglucosamine]), mono-sialyl-bis(galactosyl-N-acetylglucosaminyl); Monosialyl galactosyl biantennary glycan, core fucosylated (A1F) | 無 | C79H131N5O58 | 詳情 | 供應商 | |
| 444305-16-2 | H-GLU-LYS-PRO-LYS-VAL-GLU-ALA-TYR-LYS-ALA-ALA-ALA-ALA-PRO-ALA-OH | H-GLU-LYS-PRO-LYS-VAL-GLU-ALA-TYR-LYS-ALA-ALA-ALA-ALA-PRO-ALA-OH; H-GLU-LYS-PRO-LYS-VAL-GLU-ALA-TYR-LYS-ALA-ALA-ALA-ALA-PRO-ALA-OH; MBP (85-99) peptide antagonist trifluoroacetate salt |  | C70H114N18O21 | 詳情 | 供應商 |
| 80533-94-4 | ILE-ASN-LEU-LYS-ALA-ILE-ALA-ALA-LEU-VAL-LYS-LYS-VAL-LEU-NH2; ILE-ASN-LEU-LYS-ALA-ILE-ALA-ALA-LEU-VAL- | MAST CELL DEGRANULATING PEPTIDE HR-1; MAST CELL DEGRANULATING (MCD) PEPTIDE HR-1; MAST CELL DEGRANULATING PEPTIDE HR-1; MCD PEPTIDE HR-1; ILE-ASN-LEU-LYS-ALA-ILE-ALA-ALA-LEU-VAL-LYS-LYS-VAL-LEU-NH2; H-ILE-ASN-LEU-LYS-ALA-ILE-ALA-ALA-LEU-VAL-LYS-LYS-VAL-LEU-NH2 |  | C71H133N19O15 | 詳情 | 供應商 |
| 3979-00-8 | (2-MERCAPTOETHYL)-GUANIDINE SULFATE; (2-MERCAPTOETHYL)-GUANIDINE SULFATE; MEG SULFATE; meg hemisulfate salt; mercaptoethylguanidine hemisulfate salt |  | C3H11N3O4S2 | 詳情 | 供應商 | |
| 31884-77-2 | 無 | 詳情 | 供應商 | |||
| 97534-21-9 | MERBARONE; 5-(N-PHENYLCARBAMOYL)-2-THIOBARBITURIC ACID; 5-(N-PHENYLCARBOXAMIDO)-2-THIOBARBITURIC ACID; MERBARONE; NSC-336628; hexahydro-4,6-dioxo-n-phenyl-2-thioxo-5-pyrimidinecarboxamid; 5-(N-Phenylcarbamoyl)-2-thiobarbituric acid, NSC-336628 |  | C11H9N3O3S | 詳情 | 供應商 | |
| 29600-30-4 | MEPIQUAT IODIDE D3 (METHYL D3) |  | C7H13D3N.I | 詳情 | 供應商 | |
| 916923-10-9 | MEPHETYL TETRAZOLE; MEPHETYL TETRAZOLE; 1-[2-(4-Methoxyphenyl)ethyl]-5-(1-p-tolylcyclopropyl)-1H-tetrazole |  | C20H22N4O | 詳情 | 供應商 | |